6-(c2-6alkylseleno)purines and methods for treating neural...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 473/00 (2006.01) A61K 31/52 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2726587

The present application relates to anti-viral selenopurine compounds of formula (I) : wherein R1 is C2-6alkyl, and pharmaceutically acceptable salts, solvates, and prodrugs thereof. These 6-(C2- 6alkylseleno)purine compounds find use in the treatment of neural measles virus infection and associated diseases (namely, multiple sclerosis or neural measles). A particularly preferred compound is ethylselenopurine or ESP.

La présente invention porte sur des composés sélénopuriniques antiviraux représentés par la formule (I), dans laquelle R1 représente un groupe alkyle en C2-6, ainsi que sur les sels de qualité pharmaceutique, solvates et promédicaments de ceux-ci. Ces composés de 6-(C2- 6alkylséléno)purine sont utilisés dans le traitement d'infections neuronales dues au virus de la rougeole, ou d'une maladie associée à celles-ci (par exemple, la sclérose en plaques ou les infections neuronales dues au virus de la rougeole). Un composé particulièrement préféré est l'éthylsélénopurine, ou l' ESP.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

6-(c2-6alkylseleno)purines and methods for treating neural... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6-(c2-6alkylseleno)purines and methods for treating neural..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-(c2-6alkylseleno)purines and methods for treating neural... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1405680

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.